Journal article

Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018

Nahid Moradi, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Vahid Shaygannejad, Murat Terzi, Cavit Boz, Bassem Yamout, Recai Turkoglu, Rana Karabudak, Sherif Hamdy, Aysun Soysal, Ayse Altintas, Jihad Inshasi, Talal Al-Harbi, Raed Alroughani, Tomas Kalincik

CNS DRUGS | ADIS INT LTD | Published : 2021


BACKGROUND: The multiple sclerosis (MS) landscape has changed over the past two decades across the world and in the Middle East. The Middle East is an ethnically diverse region located between 12° and 42° of latitude and 35° and 54° of longitude and varying altitudes. The magnitude of the shifts observed in the epidemiology and management of MS differ in each region and from country to country. OBJECTIVES: The aim of this study was to provide a clinicodemographic overview of the cohorts of patients contributed to MSBase, a large international MS registry, in the Middle East and describe disease-modifying treatment (DMT) utilization in the different countries within the region. Understanding ..

View full abstract